Fidelity Investments’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.99B Sell
28,920,617
-2,276,273
-7% -$203M 0.13% 127
2026
Q1
$2.24B Sell
31,196,890
-9,821,091
-24% -$757M 0.12% 144
2025
Q4
$3.26B Sell
41,017,981
-2,317,280
-5% -$183M 0.17% 95
2025
Q3
$3.27B Sell
43,335,261
-2,274,969
-5% -$156M 0.17% 86
2025
Q2
$3.15B Buy
45,610,230
+14,716,719
+48% +$965M 0.18% 80
2025
Q1
$2.09B Buy
30,893,511
+2,760,461
+10% +$165M 0.13% 127
2024
Q4
$1.26B Sell
28,133,050
-193,991
-0.7% -$10.9M 0.08% 216
2024
Q3
$1.78B Sell
28,327,041
-1,044,903
-4% -$61M 0.11% 153
2024
Q2
$1.73B Sell
29,371,944
-5,051,337
-15% -$316M 0.11% 136
2024
Q1
$2.75B Sell
34,423,281
-3,395,503
-9% -$259M 0.18% 79
2023
Q4
$2.99B Buy
37,818,784
+10,331,546
+38% +$735M 0.23% 61
2023
Q3
$1.92B Buy
27,487,238
+6,194,441
+29% +$439M 0.17% 96
2023
Q2
$1.47B Buy
21,292,797
+7,625,848
+56% +$543M 0.12% 136
2023
Q1
$1.02B Buy
13,666,949
+3,237,567
+31% +$271M 0.09% 201
2022
Q4
$972M Sell
10,429,382
-116,918
-1% -$11.3M 0.1% 203
2022
Q3
$1.01B Sell
10,546,300
-97,105
-0.9% -$9.61M 0.1% 168
2022
Q2
$986M Sell
10,643,405
-1,273,593
-11% -$124M 0.1% 186
2022
Q1
$1.21B Sell
11,916,998
-3,612,665
-23% -$380M 0.1% 183
2021
Q4
$1.6B Sell
15,529,663
-1,298,033
-8% -$120M 0.12% 146
2021
Q3
$1.43B Sell
16,827,696
-4,947,914
-23% -$414M 0.11% 148
2021
Q2
$1.82B Sell
21,775,610
-2,286,858
-10% -$187M 0.14% 116
2021
Q1
$1.81B Sell
24,062,468
-2,340,168
-9% -$170M 0.15% 111
2020
Q4
$1.8B Sell
26,402,636
-444,738
-2% -$28.9M 0.16% 110
2020
Q3
$1.57B Sell
26,847,374
-813,994
-3% -$50.6M 0.16% 109
2020
Q2
$1.8B Sell
27,661,368
-842,607
-3% -$53.1M 0.2% 90
2020
Q1
$1.69B Buy
28,503,975
+286,851
+1% +$19.1M 0.23% 83
2019
Q4
$2.1B Sell
28,217,124
-910,782
-3% -$64M 0.23% 77
2019
Q3
$1.84B Buy
29,127,906
+1,602,226
+6% +$94.9M 0.22% 83
2019
Q2
$1.5B Sell
27,525,680
-1,755,000
-6% -$94.5M 0.18% 103
2019
Q1
$1.58B Sell
29,280,680
-9,982,585
-25% -$616M 0.19% 101
2018
Q4
$2.57B Buy
39,263,265
+9,194,005
+31% +$686M 0.35% 47
2018
Q3
$2.37B Buy
30,069,260
+1,250,473
+4% +$89.4M 0.27% 58
2018
Q2
$1.85B Sell
28,818,787
-4,789,698
-14% -$316M 0.21% 82
2018
Q1
$2.09B Sell
33,608,485
-688,006
-2% -$49.4M 0.25% 71
2017
Q4
$2.49B Buy
34,296,491
+247,592
+0.7% +$18M 0.29% 53
2017
Q3
$2.77B Buy
34,048,899
+3,898,265
+13% +$308M 0.33% 50
2017
Q2
$2.43B Buy
30,150,634
+5,446,930
+22% +$430M 0.3% 58
2017
Q1
$1.94B Sell
24,703,704
-2,691,655
-10% -$215M 0.25% 76
2016
Q4
$2.16B Sell
27,395,359
-11,802,431
-30% -$955M 0.29% 68
2016
Q3
$3.49B Sell
39,197,790
-4,912,761
-11% -$464M 0.46% 34
2016
Q2
$4.22B Sell
44,110,551
-4,756,428
-10% -$474M 0.58% 23
2016
Q1
$5.07B Buy
48,866,979
+21,004
+0% +$2.04M 0.7% 19
2015
Q4
$4.78B Sell
48,845,975
-9,966,555
-17% -$976M 0.64% 27
2015
Q3
$5.67B Buy
58,812,530
+896,659
+2% +$94.3M 0.81% 14
2015
Q2
$6.07B Buy
57,915,871
+592,583
+1% +$60.5M 0.78% 15
2015
Q1
$5.92B Sell
57,323,288
-1,066,156
-2% -$108M 0.75% 15
2014
Q4
$5.62B Buy
58,389,444
+1,704,683
+3% +$150M 0.73% 15
2014
Q3
$4.51B Sell
56,684,761
-948,455
-2% -$74.8M 0.61% 22
2014
Q2
$4.34B Buy
57,633,216
+3,288,669
+6% +$249M 0.58% 22
2014
Q1
$4.07B Sell
54,344,547
-453,518
-0.8% -$32M 0.56% 26
2013
Q4
$3.92B Sell
54,798,065
-8,672,012
-14% -$557M 0.55% 23
2013
Q3
$3.6B Sell
63,470,077
-4,532,266
-7% -$270M 0.55% 25
2013
Q2
$3.89B Buy
+68,002,343
New +$3.94B 0.64% 16

Other funds holding CVS

Fidelity Investments's CVS Position: Q2 2026 in Review

Fidelity Investments reduced its CVS Health (CVS) stake by 7.3% in Q2 2026, selling an estimated $203M and leaving 28,920,617 shares worth $2.99B. The position accounts for 0.13% of the portfolio, ranked #127.

Fidelity Investments first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.07B in Q2 2015. 2,063 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Fidelity Investments held 28,920,617 shares of CVS Health worth $2.99B as of Q2 2026.
  • Fidelity Investments sold 2,276,273 CVS Health shares in Q2 2026, an estimated $203M.
  • CVS Health made up 0.13% of Fidelity Investments's portfolio in Q2 2026, its #127 holding.
  • Fidelity Investments first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Fidelity Investments's CVS Health position peaked at $6.07B in Q2 2015.
  • 2,063 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.